US Stock MarketDetailed Quotes

BGLC BioNexus Gene Lab

Watchlist
  • 2.920
  • +0.574+24.47%
Close Apr 7 16:00 ET
  • 3.300
  • +0.380+13.01%
Pre 04:34 ET
5.25MMarket Cap24.33P/E (TTM)

BioNexus Gene Lab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EPS
According to the latest financial report of BioNexus Gene Lab, the latest earnings per share (TTM) for the company is -0.75. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about BioNexus Gene Lab's free cash flow? The latest report shows it as -1.66M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BioNexus Gene Lab shows that the company's current ratio is 4.98, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BioNexus Gene Lab, the quick ratio is 3.99, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of BioNexus Gene Lab? The latest ROE figure is -14.21%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BioNexus Gene Lab, the total asset return on investment (ROA) is -12.16%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BioNexus Gene Lab's latest financial report to see how their gross margin is doing - currently at 12.41%.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BioNexus Gene Lab, the net profit margin is -51.15%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +386.84%
Sample Name
Sample Code
 +30.00%
Sample Name
Sample Code
 +29.99%
4
QIULE SEEDS
831087
+29.98%
5
LUHENG TECHNOLOGY
870866
+29.98%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 154.140
Sample Name
Sample Code
 97.640
Sample Name
Sample Code
 175.260
4
Meta Platforms
META
516.250
5
Qualcomm
QCOM
129.720
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 2.230
Sample Name
Sample Code
 8.280
Sample Name
Sample Code
 2.670
4
CleanSpark
CLSK
7.430
5
Hive Blockchain
HIVE
1.420
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -